Burjeel Holdings Oncology Conference Celebrates 10 Years, Focusing on Equitable Solutions for Cancer Care

The 10th anniversary of the Burjeel Holdings Oncology Conference, held in partnership with Foreign Policy, brought together leading global experts to tackle the complex challenges of cancer care, emphasizing the need for multi-stakeholder collaboration. With cancer claiming millions of lives…

Read MoreBurjeel Holdings Oncology Conference Celebrates 10 Years, Focusing on Equitable Solutions for Cancer Care

QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay

 Quidel Corporation (NASDAQ: QDEL), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received 510(K) clearance from the U.S. Food and Drug Administration for its innovative Savanna PCR platform and…

Read MoreQuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay

DaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students

 The DaVita Giving Foundation has awarded Western Governors University’s (WGU) Michael O. Leavitt School of Health (LSH) a $1 million grant over the next three years to support more than 1,500 nursing students in Start Early, a program co-created by DaVita Inc. and WGU to help increase…

Read MoreDaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students

World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States

World Courier, a global specialty logistics provider and a part of Cencora (formerly AmerisourceBergen), will open transport stations in three new markets in the United States, expanding its presence and capacity to deliver specialized logistics support as the specialty pharmaceutical market continues…

Read MoreWorld Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States

Thubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter

-Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ (Optimum TAVI System™). The authorization allows for an additional 15 patients to…

Read MoreThubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter

Estée Lauder unveils its new skin longevity initiative, which is the next frontier in beauty

-Estée Lauder today unveiled its new Skin Longevity platform, which is based on 15 years of expertise in pioneering research into skin longevity. With new product innovation based on cutting-edge anti-aging technology, Estée Lauder is pioneering a new frontier in…

Read MoreEstée Lauder unveils its new skin longevity initiative, which is the next frontier in beauty

Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development

Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data. In a preprint paper published on…

Read MoreAtomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development

Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

 announced today that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the conditional approval of CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited therapy, for the treatment of severe sickle cell…

Read MoreVertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia